Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to numerous structurally and functionally different chemotherapeutic agents. MDR is considered one of the principal reasons for the failure of many forms of clinical chemotherapy. Several factors are involved in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Priya, Ambudkar, Suresh V., Rajendra Prasad, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509578/
https://www.ncbi.nlm.nih.gov/pubmed/36153528
http://dx.doi.org/10.1186/s12951-022-01626-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509578/
https://www.ncbi.nlm.nih.gov/pubmed/36153528
http://dx.doi.org/10.1186/s12951-022-01626-z

Ejemplares similares